Genvoya

treatment experienced, Treatment Naive, HIV
Treatment
2 FDA approvals
20 Active Studies for Genvoya

What is Genvoya

ElvitegravirThe Generic name of this drug
Treatment SummaryElvitegravir is a medication used to treat HIV-1 infections in adults who have already tried other antiretroviral treatments. It works by stopping the virus from replicating and spreading. Elvitegravir must be taken in combination with other medications, including an HIV protease inhibitor, ritonavir, and another antiretroviral drug. It was first licensed in 2008 and approved by the FDA in 2012. In 2014, the single pill form of elvitegravir was approved.
Stribildis the brand name
image of different drug pills on a surface
Genvoya Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Stribild
Elvitegravir
2012
10

Approved as Treatment by the FDA

Elvitegravir, also known as Stribild, is approved by the FDA for 2 uses which include treatment experienced and HIV .
treatment experienced
HIV

Effectiveness

How Genvoya works in the bodyElvitegravir is an anti-HIV drug that stops the virus from replicating. It does this by blocking the enzyme called integrase, which is needed for HIV-1 to spread. Elvitegravir does not affect the host's own topoisomerases, which are enzymes involved in DNA regulation.

When to interrupt dosage

The proposed measure of Genvoya is contingent upon the perceived condition, including treatment experienced, Treatment Naive and HIV (Human Immunodeficiency Virus). The amount of dosage relies upon the technique of delivery (e.g. Tablet, film coated or Tablet) delineated in the table hereunder.
Condition
Dosage
Administration
Treatment Naive
150.0 mg, , 85.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
treatment experienced
150.0 mg, , 85.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
HIV
150.0 mg, , 85.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral

Warnings

Genvoya Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Genvoya.
Common Genvoya Drug Interactions
Drug Name
Risk Level
Description
1,2-Benzodiazepine
Major
The metabolism of 1,2-Benzodiazepine can be decreased when combined with Elvitegravir.
3,5-diiodothyropropionic acid
Major
The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Elvitegravir.
5-androstenedione
Major
The metabolism of 5-androstenedione can be decreased when combined with Elvitegravir.
6-O-benzylguanine
Major
The metabolism of 6-O-benzylguanine can be decreased when combined with Elvitegravir.
7-ethyl-10-hydroxycamptothecin
Major
The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Elvitegravir.
Genvoya Toxicity & Overdose RiskTaking elvitegravir may lead to nausea, vomiting, diarrhea, abdominal pain, indigestion, fatigue, insomnia, rash, depression, and suicidal thoughts or attempts. These side effects are not very common and occur in fewer than 2% of patients.
image of a doctor in a lab doing drug, clinical research

Genvoya Novel Uses: Which Conditions Have a Clinical Trial Featuring Genvoya?

43 active clinical trials are assessing the potential of Genvoya in managing HIV (Human Immunodeficiency Virus) in both Treatment Naive and Treatment Experienced Patients.
Condition
Clinical Trials
Trial Phases
treatment experienced
0 Actively Recruiting
HIV
38 Actively Recruiting
Phase 2, Phase 3, Early Phase 1, Not Applicable, Phase 1, Phase 4
Treatment Naive
0 Actively Recruiting

Genvoya Reviews: What are patients saying about Genvoya?

5Patient Review
5/21/2017
Genvoya for HIV
I was diagnosed in April 2017 and have been amazed by the progress of my treatment.
5Patient Review
10/18/2016
Genvoya for HIV
This treatment is very simple, just one pill a day. I did experience some dizziness, but it was nothing compared to other drugs I've been prescribed.
5Patient Review
12/22/2016
Genvoya for HIV
I'm really pleased with genvoya. I started taking it on 8/1/2016 and haven't had a single side effect. In fact, not only did it get rid of a rash I had on my leg, but it did so within a month.
5Patient Review
4/28/2017
Genvoya for HIV
I'm pregnant and so far this medication has had zero negative side effects that I can tell.
5Patient Review
12/30/2017
Genvoya for HIV
I appreciate that I only have to take this medication once per day, and that there are no side effects. I've been on it for over two years now, and it has helped me immensely.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about genvoya

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you drink alcohol while taking Genvoya?

"Most people can drink alcohol while taking Genvoya without any interactions."

Answered by AI

Is Genvoya the same as Biktarvy?

"Genvoya and Biktarvy are both antiretrovirals that contain elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Biktarvy also contains bictegravir."

Answered by AI

Does Genvoya make you undetectable?

"In a study of people with HIV-1, those who switched to taking GENVOYA® were 93% more likely to still have an undetectable viral load after two years of treatment, as compared to those who stayed on their current treatment."

Answered by AI

What is Genvoya used to treat?

"Genvoya is a once-daily pill for treating HIV that combines four drugs: 150mg elvitegravir, 200mg emtricitabine, 10mg tenofovir alafenamide, and 150mg cobicistat. The green film-coated tablet bears the markings "GSI" on one side and "510" on the other."

Answered by AI

What are the side effects of Genvoya?

"Some common symptoms of HIV include nausea, diarrhea, fatigue, headaches, and changes in body fat distribution."

Answered by AI

Clinical Trials for Genvoya

Have you considered Genvoya clinical trials? We made a collection of clinical trials featuring Genvoya, we think they might fit your search criteria.
Have you considered Genvoya clinical trials? We made a collection of clinical trials featuring Genvoya, we think they might fit your search criteria.
Have you considered Genvoya clinical trials? We made a collection of clinical trials featuring Genvoya, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top